GleamWall
中文EN

ACBM ACRO BIOMEDICAL CO., LTD.

Services-Amusement & Recreation Services · OTC · SEC CIK 1622996 · Fiscal year ends 12/31

Financial factors as of 2026-06-30 (2026Q2), TTM = sum of the last four quarters

Growth

TTM revenue YoY—
TTM net income YoY-200.3%
TTM EPS YoY—
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—

Returns

ROE—
ROA-493.3%
ROIC (approx.)—
Asset turnover0.00x

Leverage & solvency

Liabilities / assets12,292.7%
Debt / equity—
Current ratio0.01x
Interest coverage—

Cash quality & payout

Operating cash flow / net income1.00x
Accruals ratio-1.1%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-312024Q32024-09-30
Income statement
Revenue$0$0$0$0$0$0$0$0
R&D expense——————$0$0
SG&A expense$17,554$60,271$16,377$115,099$13,614$8,934$9,468$9,106
Operating income-$17,554-$60,271-$16,377-$115,099-$13,614-$8,934-$9,468-$9,106
Interest expense—————$22,306—$6,110
Pretax income——$42,526-$117,809-$15,562-$10,301-$10,673-$10,229
Income tax——$0$0$0$0$0$0
Net income-$21,356-$43,774$42,526-$117,809-$15,562-$10,301-$10,673-$10,229
EPS (diluted)0.000.00—0.000.000.00—0.00
Weighted avg. shares (diluted)60.04M60.04M—60.04M60.04M60.04M—60.04M
Balance sheet
Cash & equivalents$3,648$3,873$4,098$4,323$26$251$476$701
Current assets$3,648$3,873$14,098$4,323$39,626$4,851$5,076$701
Total assets$3,648$3,873$14,098$4,323$53,277$25,175$31,974$38,676
Current liabilities$448,437$431,108$401,062$436,942$370,797$329,081$326,946$317,304
Total liabilities$448,437$431,108$401,062$436,942$370,797$329,081$326,946$324,180
Shareholders' equity-$444,789-$427,235-$386,964-$432,619-$317,520-$303,906-$294,972-$285,504
Shares outstanding60.04M60.04M60.04M60.04M60.04M60.04M60.04M60.04M
Cash flow statement
Operating cash flow-$10,504-$49,821-$25,377-$54,410-$93,984-$22,531-$10,515-$6,335
Financing cash flow$10,279$49,596$25,152$58,707$93,759$22,306$10,290$6,110

Free plan shows the latest 8 periods; Pro shows all 46 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.